Identification and analysis of DNA repair mechanisms that contribute to resistance against nucleoside analogues. Referencing Requirements: Blagosklonny, M. 2005, “Carcinogenesis, cancer therapy and chemoprevention”, Cell Death & Differentiation, vol. 12, no. 6, pp. 592- 602. Bunn, P.A.,Jr 1999, “Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer”, Seminars in oncology, vol. 26, no. 1 Suppl 4, pp. 25-30. Deshpande, G.P., Hayles, J., Hoe, K.L., Kim, D.U., Park, H.O. & Hartsuiker, E. 2009, “Screening a genome-wide S. pombe deletion library identifies novel genes and pathways involved in genome stability maintenance”, DNA repair, vol. 8, no. 5, pp. 672-679. Evan, G.I. & Vousden, K.H. 2001, “Proliferation, cell cycle and apoptosis in cancer”, Nature, vol. 411, no. 6835, pp. 342-348. Galmarini, C.M., Mackey, J.R. & Dumontet, C. 2002, “Nucleoside analogues and nucleobases in cancer treatment”, The lancet